Risk factors for febrile genito-urinary infection in the catheterized patients by with spinal cord injury-associated chronic neurogenic lower urinary tract dysfunction evaluated by urodynamic study and cystography: a retrospective study
Introduction To investigate the risk factors for febrile genito-urinary tract infection (GUTI) in spinal cord injury-associated neurogenic lower urinary tract dysfunction (NLUTD) patients who perform routine clean intermittent catheterization (CIC) evaluated by urodynamic study (UDS) and cystography...
Gespeichert in:
Veröffentlicht in: | World journal of urology 2020-03, Vol.38 (3), p.733-740 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction
To investigate the risk factors for febrile genito-urinary tract infection (GUTI) in spinal cord injury-associated neurogenic lower urinary tract dysfunction (NLUTD) patients who perform routine clean intermittent catheterization (CIC) evaluated by urodynamic study (UDS) and cystography.
Patients and methods
Over a 3-year period, we retrospectively assessed risk factors for febrile UTI in 141 spinal cord injury patients diagnosed as NLUTD and performing routine CIC, regarding gender, UDS findings such as bladder compliance, maximum cystometric capacity, and cystography.
Results
A total of 41 patients had febrile GUTI in the follow-up period as along with 32 cases of pyelonephritis, 10 cases of epididymitis, and 1 case of prostatitis, including patients with multiple infectious diseases. The causative bacteria were
Escherichia coli
(14 cases) followed by
Pseudomonas aeruginosa
(
n
= 5),
Klebsiella pneumoniae
(
n
= 4), and
Klebsiella oxytoca
(
n
= 4). Antibiotic-resistant
E. coli
were seen, with 36.4% instances of extended-spectrum beta-lactamase production in whole of
E. coli
. Male gender (
p
= 0.018), ASIA Impairment Scale (AIS) C or more severe (
p
= 0.031), the number of CIC (
p
= 0.034), use of quinolones (
p
|
---|---|
ISSN: | 0724-4983 1433-8726 |
DOI: | 10.1007/s00345-019-02743-5 |